The two-volume set is meticulously organized to reflect the logical flow of clinical reasoning: Pathophysiology → Diagnosis → Management. This structure is a defining characteristic of the text, ensuring that clinicians understand why a disease occurs before attempting to treat it.
1. Comprehensive Coverage: The text covers the entire spectrum of gastrointestinal and liver diseases, including:
2. Updates in the 12th Edition: This edition reflects the significant shifts in gastroenterology over the last several years:
3. Visual and Digital Enhancements:
Target Audience: Gastroenterologists, Hepatologists, Internal Medicine Physicians, GI Fellows, NPs/PAs in GI
Core Focus: Pathophysiology, evidence-based diagnosis, advanced therapeutics, emerging technologies
Defining Features of the 12th Edition (New Content Areas):
The 12th edition is helmed by a prestigious editorial team:
The 12th Edition is edited by a powerhouse team of experts, led by Dr. Henry P. Parkman and Dr. Robert S. Fisher, alongside associate editors who are leaders in their respective subspecialties. This team ensures that the text maintains the rigorous academic standards established by its original namesakes, Dr. Marvin Sleisenger and Dr. John Fordtran, while injecting contemporary perspectives.
The Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 12th Edition is available in multiple formats:
Review Question Book: Do not confuse the main textbook with Sleisenger and Fordtran's Gastrointestinal and Liver Disease Review, 12th Edition (sold separately). The review book contains over 1,000 board-style questions with detailed rationales—essential for exam preparation.
The 12th Edition of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease is not just a textbook; it is an investment in clinical excellence. By successfully marrying the intricate science of pathophysiology with the practical demands of modern management, it remains the undisputed authority in the field. For any medical professional serious about mastering gastroenterology, this text remains an essential addition to their library.
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease
was released on December 10, 2025. As the definitive reference for gastroenterology and hepatology for over 50 years, this two-volume masterwork continues to provide comprehensive coverage of pathophysiology, diagnosis, and management. Key Updates and New Features
The 12th edition introduces significant content updates reflecting the latest advancements in the field:
New Editorial Team: The work is now guided by senior editors Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox.
Expanded Clinical Topics: Features new and expanded discussions on MASLD (metabolic dysfunction-associated steatotic liver disease), eosinophilic disorders, and the array of new treatments for IBD.
New Chapters: Includes specialized chapters on gastrointestinal and hepatic manifestations of COVID-19, as well as enterocolitis and hepatitis induced by cancer immunotherapy.
AI Integration: Coverage of the use of artificial intelligence in endoscopy for the improved detection of gastrointestinal cancers.
Visual and Technical Aids: The edition includes over 1,100 full-color illustrations, clinically practicable algorithms, and more than 20 procedural videos. Book Specifications Publisher Elsevier Publication Date December 10, 2025 Page Count 2,560 pages Format 2-Volume Set (Hardcover) or eBook ISBN-13 978-0443116575
The 12th edition remains available for purchase at major retailers like Amazon, Barnes & Noble, and VitalSource.
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
The 12th edition of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease is the gold standard reference text in the field. While its size and density may intimidate novices, it is an indispensable resource for anyone who needs to master digestive diseases. The updates in microbiome science, immunotherapy-related GI toxicity, and endoscopic techniques keep it relevant in a rapidly evolving specialty. For practicing gastroenterologists, it remains the most trusted companion for answering complex clinical questions and preparing for recertification. For fellows, it is the mountain they must climb—and the 12th edition makes the ascent as well-mapped as possible.
Recommended citation:
Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 12th ed. Elsevier; 2020.
ISBN: 978-0-323-71008-6 (2-volume set)
Title: An Evolving Paradigm: A Review of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, 12th Edition
Abstract For over four decades, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease has served as the definitive reference for the diagnosis and management of digestive disorders. The release of the 12th edition arrives at a critical juncture in medical history, bridging the gap between classical pathophysiology and the rapid advancements in immunology, genomics, and interventional endoscopy. This paper provides a comprehensive review of the 12th edition, analyzing its structural organization, the integration of current clinical guidelines, and its adaptation to the digital age of evidence-based medicine. Special attention is given to the text's expanded coverage of the microbiome, liver transplantation, and the implications of the COVID-19 pandemic on gastroenterological practice.
1. Introduction The field of gastroenterology is characterized by a unique duality: it is deeply rooted in the mechanical understanding of hollow organ systems while simultaneously standing at the forefront of biotechnological innovation. Since its inception, Sleisenger and Fordtran has been the gold standard text for translating complex physiological mechanisms into clinical practice. The 12th edition, published against the backdrop of a global pandemic and an explosion of biological therapeutics, faces the challenge of maintaining its encyclopedic depth while remaining clinically relevant. This paper explores how the 12th edition meets this challenge, serving not merely as a textbook, but as a comprehensive roadmap for the modern gastroenterologist.
2. Structure and Scope The 12th edition maintains the two-volume format familiar to its readership, organized anatomically and physiologically. However, a notable shift in this edition is the streamlined organization of sections to facilitate rapid information retrieval. The text is divided into distinct biological and clinical sections:
The editors have successfully navigated the tension between print limitations and the vast expansion of medical knowledge. The inclusion of over 1,000 full-color illustrations and endoscopic images is not merely aesthetic but pedagogical, providing visual correlates for the pathological descriptions found in the text.
3. Key Updates and Advancements
3.1 The Microbiome and Environmental Factors Perhaps the most significant update in the 12th edition is the deepened focus on the gut microbiome. Previous editions introduced the concept; the 12th edition integrates it into the pathogenesis of numerous conditions. The text thoroughly revisits the role of dysbiosis in Inflammatory Bowel Disease (IBD), irritable bowel syndrome (IBS), and metabolic syndrome. Furthermore, the editors have expanded the section on environmental risk factors, reflecting current literature on diet, antibiotics, and their long-term impact on gut health.
3.2 Advances in Therapeutics and Endoscopy The "Therapeutic" sections have undergone substantial revision. The management of Hepatitis C, a rapidly evolving field, is updated to reflect the pan-genotypic direct-acting antivirals (DAAs) that have revolutionized cure rates. Similarly, the section on IBD has been overhauled to include the latest biologics and small molecule inhibitors (JAK inhibitors), offering clear algorithms for step-up versus top-down therapeutic approaches. Interventional endoscopy receives significant attention, with expanded chapters on endoscopic ultrasound (EUS), endoscopic submucosal dissection (ESD), and endoscopic bariatric therapies. These chapters bridge the gap between gastroenterology and surgery, highlighting the shift toward minimally invasive treatments.
3.3 Hepatology and Transplantation Hepatology continues to grow in complexity. The 12th edition offers robust updates on Non-Alcoholic Fatty Liver Disease (NAFLD) and its progressive counterpart, Non-Alcoholic Steatohepatitis (NASH), acknowledging the rising global prevalence of metabolic syndrome. The liver transplantation protocols are updated to reflect current organ allocation policies (MELD score evolution) and post-transplant immunosuppression strategies, providing a vital resource for hepatologists and surgeons alike.
3.4 The Impact of COVID-19 A distinguishing feature of this edition is its inclusion of data regarding the SARS
Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 12th Edition, is widely considered the definitive "gold standard" reference for gastroenterology. Published in late 2025 and early 2026, this latest edition is managed by a new senior editorial team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox. Key Updates and "What’s New"
The 12th edition reflects rapid advancements in GI and hepatology, introducing several critical updates:
Modern Pathology Chapters: New dedicated chapters address Gastrointestinal and Hepatic Manifestations of Coronavirus Infection (COVID-19) and Enterocolitis and Hepatitis Induced by Cancer Immunotherapy.
AI and Technology: Features expanded discussions on the use of Artificial Intelligence (AI) in endoscopy for improved detection of GI cancers.
Liver Disease Evolution: Significant updates to MASLD (Metabolic dysfunction-associated steatotic liver disease, formerly NAFLD) and new treatments for viral hepatitis and autoimmune liver diseases.
Expanded Sections: A new section on Neoplasia Involving Multiple Organs and broader coverage of inflammatory bowel disorders (IBD). Practical Learning Features
Designed for both deep study and quick clinical reference, the 12th edition includes:
Visual Aids: Over 1,100 full-color illustrations and more than 20 procedural videos covering endoscopic techniques like balloon dilatation and stent placement.
Clinical Algorithms: Quick-reference algorithms are used throughout to summarize complex decision-making and patient management.
Templated Format: A consistent, templated chapter design allows for high-speed scannability during busy clinical shifts.
Enhanced eBook: Purchases typically include an eBook version with searchable text, highlighting tools, and read-aloud capabilities.
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
Sleisenger and Fordtran's Gastrointestinal and Liver Disease: 12th Edition – The Gold Standard in Gastroenterology
For over fifty years, one textbook has stood above all others as the definitive source for clinical gastroenterology and hepatology. The release of Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 12th Edition, continues this legacy, providing a comprehensive, evidence-based foundation for clinicians, fellows, and residents worldwide.
In an era where medical knowledge evolves at a breakneck pace, the 12th edition arrives as an essential update, bridging the gap between cutting-edge research and bedside practice. What’s New in the 12th Edition?
The 12th edition isn't just a reprint; it is a thorough overhaul designed to reflect the current landscape of digestive health. 1. Advanced Microbiome Insights
Our understanding of the human gut microbiome has exploded. This edition integrates the latest science on how microbial communities influence everything from Inflammatory Bowel Disease (IBD) to metabolic disorders and liver health. 2. Precision Medicine and Genetics s gastrointestinal and liver disease 12th edition
The shift toward personalized care is a major theme. The text explores genetic markers, biological therapies, and targeted treatments that allow physicians to move beyond a "one size fits all" approach to complex diseases. 3. Expanded Hepatology Coverage
With the rise of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)—formerly NAFLD—and breakthroughs in Hepatitis C and cirrhosis management, the liver sections have been significantly expanded to provide the most current clinical pathways. 4. Minimally Invasive Innovations
The 12th edition highlights the latest in diagnostic and therapeutic endoscopy, including EUS (Endoscopic Ultrasound) and ERCP, as well as the expanding role of robotic surgery in gastrointestinal care. Core Features That Set It Apart
Multidisciplinary Approach: Content is curated by a world-class team of editors (Mark Feldman, Lawrence S. Friedman, and Lawrence J. Brandt) and hundreds of expert contributors, ensuring a balanced view from both medical and surgical perspectives.
Radiology and Pathology Integration: Thousands of high-quality illustrations, anatomical drawings, and clinical photos help clinicians correlate symptoms with visual findings.
Summary Tables and Algorithms: For the busy practitioner, the 12th edition utilizes clear, concise tables and treatment algorithms that make decision-making faster and more accurate.
Comprehensive Evidence Base: Every chapter is backed by the most recent clinical trials and consensus guidelines, making it the primary reference for board exams and certification. Why Every GI Specialist Needs the 12th Edition
Whether you are a seasoned gastroenterologist or a trainee preparing for the boards, this textbook serves as a "living" document of the field. It covers the full spectrum of digestive health:
Esophageal and Gastric Disorders: From GERD and motility issues to peptic ulcer disease.
Small and Large Intestine: Deep dives into Celiac disease, Crohn’s, Ulcerative Colitis, and IBS.
Pancreatico-Biliary System: Comprehensive management of pancreatitis and gallstone disease.
Liver Disease: Updates on transplantation, autoimmune hepatitis, and oncology. Conclusion
Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 12th Edition remains the most trusted encyclopedia of the digestive system. By combining foundational pathophysiology with the latest technological and pharmacological breakthroughs, it ensures that practitioners are equipped to provide the highest level of patient care.
In the complex and ever-changing world of gastroenterology, this is the one resource you cannot afford to be without.
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Overview of S. Gastrointestinal and Liver Disease 12th Edition
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease is a comprehensive reference text that provides authoritative guidance on the diagnosis, treatment, and management of gastrointestinal and liver disorders. This esteemed textbook has been a trusted resource for gastroenterologists, hepatologists, and other healthcare professionals for over 50 years.
Key Features of the 12th Edition
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease has been thoroughly revised and updated to reflect the latest advances in the field. Some of the key features of this edition include:
Major Updates in the 12th Edition
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease includes several major updates, including:
Target Audience
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease is an essential resource for:
Overall, the 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease is a comprehensive and authoritative reference text that provides healthcare professionals with the knowledge and expertise needed to diagnose, treat, and manage gastrointestinal and liver disorders.
The release of Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 12th Edition, marks a pivotal moment for gastroenterologists, hepatologists, and internal medicine specialists worldwide. For over fifty years, this text has served as the "gold standard" or the "bible" of digestive health.
The new edition doesn't just update the facts; it refines the clinical approach to some of the most complex challenges in modern medicine. Here is an in-depth look at why the 12th edition remains the cornerstone of the field. A Legacy of Clinical Excellence
What sets Sleisenger and Fordtran apart is its ability to bridge the gap between basic science and clinical practice. While many textbooks focus heavily on pathophysiology, the 12th edition maintains a relentless focus on the patient. It provides a comprehensive framework for diagnosing and managing the full spectrum of digestive diseases, from common ailments like GERD and IBS to rare autoimmune hepatobiliary disorders. Key Updates in the 12th Edition
The field of gastroenterology moves fast, and the 12th edition has been meticulously updated to reflect the latest breakthroughs:
Advancements in Microbiome Research: Perhaps no area has grown faster than our understanding of the gut microbiome. The new edition provides updated insights into how microbial imbalances contribute to inflammatory bowel disease (IBD), obesity, and even systemic metabolic health.
The Evolution of IBD Management: With the explosion of biologics and small-molecule therapies (like JAK inhibitors), the 12th edition offers a modernized roadmap for personalized IBD treatment, focusing on "treat-to-target" strategies.
Modern Hepatology: From the rebranding of NAFLD to MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) to the latest curative protocols for Hepatitis C and management of cirrhosis complications, the liver sections are more robust than ever.
Endoscopic Innovations: The text covers the latest in therapeutic endoscopy, including third-space endoscopy (POEM), advanced imaging techniques, and the expanding role of interventional EUS. Features That Enhance Learning
The 12th edition is designed for both deep study and quick clinical reference:
Expert Consult Integration: The digital version allows for searchable access on multiple devices, making it easy to pull up a high-resolution image or a specific drug dosage while on rounds.
Exceptional Visuals: Thousands of full-color illustrations, clinical photos, and anatomical drawings help clarify complex procedures and pathological findings.
Summary Tables: High-yield boxes and algorithms allow clinicians to quickly digest the "bottom line" for management and follow-up. Why Every GI Professional Needs This Edition
In an era of "information overload," having a curated, peer-reviewed, and authoritative source is more valuable than ever. The 12th edition is edited by a team of world-renowned experts—Mark Feldman, Lawrence S. Friedman, and Lawrence J. Brandt—ensuring that every chapter reflects the highest standard of academic and clinical integrity.
Whether you are preparing for board exams, looking for evidence-based answers for a difficult case, or staying current with the latest guidelines, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, 12th Edition is an indispensable resource. Final Thoughts
The 12th edition is more than just a textbook; it is a comprehensive clinical partner. By integrating the latest genomic data, therapeutic breakthroughs, and diagnostic technologies, it ensures that practitioners are equipped to provide the best possible care for patients with digestive and liver disorders.
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Unlocking the Secrets of Gastrointestinal and Liver Diseases: A Comprehensive Review of the 12th Edition
For decades, Sleisenger and Fordtran's Gastrointestinal and Liver Disease has been the go-to reference for gastroenterologists, hepatologists, and medical professionals seeking in-depth knowledge on the diagnosis, treatment, and management of gastrointestinal and liver disorders. The 12th edition of this esteemed textbook continues to uphold its reputation as a trusted and authoritative resource, offering cutting-edge insights and practical guidance for healthcare providers.
What's New in the 12th Edition?
The latest edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease boasts significant updates, including:
Key Features of the 12th Edition
Who Will Benefit from This Textbook?
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease remains an essential resource for anyone involved in the diagnosis, treatment, and management of gastrointestinal and liver disorders. With its comprehensive coverage, rich illustrations, and clinical pearls, this textbook continues to set the standard for excellence in gastroenterology and hepatology.
12th edition Sleisenger and Fordtran's Gastrointestinal and Liver Disease , published by
in December 2025, represents a significant update to what remains the definitive reference for gastroenterology and hepatology. Key Updates & New Chapters
The 12th edition introduces essential topics reflecting modern medical challenges and technological advancements: Viral and Autoimmune Liver Disease The two-volume set is meticulously organized to reflect
: Features updated treatment protocols and expanded discussions on
(metabolic dysfunction-associated steatotic liver disease, formerly NAFLD). Artificial Intelligence (AI)
: New coverage of AI applications in endoscopy to enhance the detection of gastrointestinal cancers. COVID-19 Impact
: A dedicated new chapter on the gastrointestinal and hepatic manifestations of coronavirus infections. Immunotherapy Complications
: New insights into enterocolitis and hepatitis induced by cancer immunotherapy. Inflammatory Bowel Disorders (IBD)
: Expanded array of new biological treatments and small molecules. US Elsevier Health Enhanced Clinical Utility Editorial Leadership
: Guided by a new senior team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox. Decision-Making Tools : Includes over 1,100 full-color illustrations
and quick-reference algorithms to streamline clinical diagnosis and patient management. Multimedia Content : Provides access to more than
of advanced endoscopic procedures, such as balloon dilatation and stent placement. Comprehensive Scope
: Covers the full spectrum from basic science and anatomy to advanced therapeutic techniques like liver transplantation and molecular diagnostics. US Elsevier Health Product Specifications Release Date December 10, 2025 (varies by region to Dec 24) 2-Volume Set (Hardcover) or E-Book Page Count Approximately 2,536–2,560 pages Available at companion book or details on the new AI endoscopy techniques
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Sleisenger and Fordtran's Gastrointestinal and Liver Disease - 2 Volume Set - 12th Edition | Elsevier Shop
Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 12th Edition
remains the "gold standard" reference for gastroenterologists, hepatologists, and trainees, offering a comprehensive blend of basic science, clinical diagnosis, and the latest management strategies. Key Features & Updates
Modernized Clinical Guidance: This edition features expanded discussions on MASLD (metabolic dysfunction-associated steatotic liver disease), eosinophilic disorders, and the application of AI in endoscopy for GI cancer detection.
New Specialized Chapters: Addresses contemporary challenges with new chapters on the GI and hepatic manifestations of Coronavirus and enterocolitis induced by cancer immunotherapy.
Visual & Practical Tools: Includes over 1,100 full-color illustrations and 20+ procedural videos. Quick-reference algorithms are designed to streamline clinical decision-making in high-pressure environments.
New Editorial Leadership: Managed by a new senior team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox, ensuring the content reflects current leadership in the field. Critical Reception
Comprehensive Scope: Experts from Elsevier Health and academic reviewers consistently rate it as an indispensable resource that covers everything from basic pathophysiology to advanced endoscopic procedures.
Formatting for Speed: Reviewers appreciate the consistent, templated format which allows for rapid information retrieval during clinical rounds.
User Feedback: Global customer reviews on Amazon average 4.1 out of 5 stars, with high praise for its informative depth, though some international buyers have noted logistical issues like receiving only one volume of the two-volume set. Purchase Information
The 12th Edition is a two-volume set available in both hardcover and digital formats. Amazon.in: ~20,750 INR Elsevier Shop: Includes an eBook version with purchase DNA Mart: ~20,999 INR
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Sleisenger and Fordtran's Gastrointestinal and L: 12th edition
12th edition of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease
(published December 2025) remains the gold-standard reference for gastroenterology and hepatology. Led by a new senior editorial team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox, this two-volume set integrates basic science with the latest clinical technologies and treatments. Core Themes and New Chapters
The 12th edition introduces specific chapters that address contemporary global health challenges and evolving scientific understanding:
Gastrointestinal and Hepatic Manifestations of Coronavirus Infection
: A new chapter dedicated to the long-term and acute impacts of COVID-19 on the digestive system. Cancer Immunotherapy Side Effects
: A new chapter on Enterocolitis and Hepatitis induced by cancer immunotherapy, reflecting the rise of biological treatments in oncology. Microbiota and Probiotics
: Expanded focus on the enteric microbiota, fecal microbiota transplantation, and the role of the gut-brain axis in disease. Artificial Intelligence (AI)
: New discussions on using AI in endoscopy to enhance the detection of gastrointestinal cancers. Major Clinical Updates Liver Disease Nomenclature : Transition to the term
(metabolic dysfunction-associated steatotic liver disease), formerly known as non-alcoholic fatty liver disease (NAFLD). Advanced Hepatology
: Detailed updates on the treatment of viral hepatitis, autoimmune liver diseases, and the management of cirrhosis complications. Inflammatory Bowel Disease (IBD)
: Extensive new data on biologics and novel small molecules for treating and preventing IBD recurrences. Obesity Management
: Updated sections on the surgical and endoscopic treatment of obesity, reflecting the shift toward minimally invasive interventions. Structure and Educational Features Templated Format
: Organized into 11 sections and 132 chapters for consistent, quick information retrieval. Visual Aids
: Contains more than 1,100 full-color illustrations and dozens of procedural videos accessible via the Elsevier Expert Consult eBook Clinical Algorithms
: High-speed scannable decision-making tools that summarize patient management for complex GI cases. specific summary of one of the new clinical topics like MASLD?
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
For more than 50 years, Sleisenger and Fordtran's Gastrointestinal and Liver Disease
has remained the definitive reference for gastroenterology and hepatology professionals. The upcoming 12th Edition , scheduled for release in December 2025
, provides a comprehensive two-volume update on the pathophysiology, diagnosis, and management of GI and liver conditions. Key Features and Updates
The 12th edition is guided by a new senior editorial team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox . Major updates include: US Elsevier Health New Clinical Discussions
: Expanded coverage of eosinophilic disorders, autoimmune liver diseases, and the latest treatments for viral hepatitis. Renamed Conditions : Incorporation of new terminology, such as
(metabolic dysfunction-associated steatotic liver disease), formerly known as NAFLD. New Chapters
: Dedicated sections on the gastrointestinal and hepatic manifestations of , as well as enterocolitis and hepatitis induced by cancer immunotherapy Advanced Technology : Updated insights into the use of AI in endoscopy for improved detection of GI cancers. Visual and Practical Aids : Over 1,100 full-color illustrations and more than 20 procedural videos
covering endoscopic techniques like balloon dilatation and stent placement. Reference Details Elsevier Health Sciences Publication Date 10–15 December 2025 978-0443116575 Page Count Approx. 2,500–3,700 pages (2-Volume Set) Target Audience
Gastroenterologists, hepatologists, residents, fellows, and medical students Availability and Pricing scheduled for release in December 2025
The 12th edition is available for pre-order at several retailers: Elsevier Health : Offers the Complete 2-Volume Set for approximately ₹31,844 : Lists the hardcover 2-volume set at for ₹20,750. Specialized Medical Bookstores : Retailers like Naresh Book Store (₹20,485) and (₹20,999 ) offer pre-publication pricing. US Elsevier Health digital eBook access included with this edition?
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
12th Edition Sleisenger and Fordtran's Gastrointestinal and Liver Disease released on December 10, 2025
. This comprehensive update to the "definitive GI reference" introduces several new clinical chapters and reflects major shifts in the management of digestive and hepatic conditions. Key Updates & New Content The latest edition, edited by experts like Raymond T. Chung David T. Rubin , features significant expansions: Novel Pathologies: New chapters covering Gastrointestinal and Hepatic Manifestations of COVID-19 Enterocolitis and Hepatitis Induced by Cancer Immunotherapy Advanced Technology: Detailed discussion on the use of AI in endoscopy to improve the detection of GI cancers. Updated Terminology: Comprehensive coverage of
(Metabolic dysfunction-associated Steatotic Liver Disease), reflecting the shift from the former NAFLD nomenclature. Therapeutic Advances: Updates on new treatments for viral hepatitis
, autoimmune liver diseases, and the expanding array of biologics for inflammatory bowel disorders (IBD) Clinical Utility
Designed for both seasoned clinicians and fellows, the 12th edition includes: Visual Learning: 1,000 illustrations and photographs, with 400 in full color. Procedural Content: 35 new procedural videos through the digital version. Decision Support: quick-reference algorithms to assist in bedside clinical decision-making. Google Books
The book is available through major medical retailers such as Barnes & Noble new management algorithms included for a specific disease, such as
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Sleisenger and Fordtran's Gastrointestinal and Liver Disease - Elsevier
The Golden Standard Returns: Exploring Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, 12th Edition For over five decades, Sleisenger & Fordtran's Gastrointestinal and Liver Disease
has served as the definitive reference for the global GI community . The newly released 12th edition
continues this legacy, offering a modern, two-volume masterwork that bridges basic science with the latest clinical technologies.
Whether you are a seasoned gastroenterologist, a student, or part of a multi-disciplinary care team, this edition provides the "gold standard" knowledge needed to navigate the complexities of modern hepatology and gastroenterology. What’s New in the 12th Edition? Guided by a new senior editorial team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox
, this edition introduces critical updates to reflect the rapidly evolving landscape of GI care: Cutting-Edge Clinical Chapters
: New dedicated sections cover the gastrointestinal and hepatic manifestations of Coronavirus infection , as well as enterocolitis and hepatitis induced by cancer immunotherapy AI and Technology : Detailed discussions on the use of artificial intelligence in endoscopy for the improved detection of GI cancers. Expanded Liver Disease Coverage : Updated terminology and management for
(metabolic dysfunction-associated steatotic liver disease, formerly NAFLD), along with new treatments for viral hepatitis and autoimmune liver diseases. Therapeutic Advancements : A look into the expanded array of new treatments for inflammatory bowel disorders (IBD) and novel small molecules. Designed for Clinical Practice
This edition is more than just a textbook; it is a practical tool designed for quick retrieval of high-stakes information:
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
You're looking for information on the 12th edition of "Sleisenger and Fordtran's Gastrointestinal and Liver Disease". Here's what I found:
Overview
Sleisenger and Fordtran's Gastrointestinal and Liver Disease is a comprehensive medical textbook that provides in-depth coverage of gastrointestinal and liver diseases. The 12th edition is the latest version of this renowned textbook.
Key Features
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease features:
Chapter Outline
The 12th edition is divided into several sections, including:
Target Audience
This textbook is aimed at:
Availability
The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease is available in various formats, including:
If you're looking for more specific information or would like to purchase a copy, I recommend visiting the Elsevier website or checking with your local medical bookstore.
The 12th Edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease
, scheduled for release in December 2025, is a comprehensive two-volume masterwork that serves as the definitive reference for gastroenterology and hepatology. Key Highlights of the 12th Edition
New Editorial Team: Guided by Raymond T. Chung, David T. Rubin, and C. Mel Wilcox.
Expanded Clinical Topics: Includes updated discussions on eosinophilic disorders, MASLD (Metabolic dysfunction-associated steatotic liver disease), and the latest treatments for inflammatory bowel disorders (IBD).
Technological Advances: Features the use of AI in endoscopy for GI cancer detection and new sections on molecular diagnostics.
Modern Pathology: New chapters covering COVID-19 manifestations in the GI tract and liver, as well as cancer immunotherapy-induced enterocolitis and hepatitis.
Multimedia Integration: Over 1,100 full-color illustrations and more than 20 procedural videos are included in the enhanced eBook version. Table of Contents (Summary of Major Parts)
The textbook is organized logically across 11 primary sections comprising 132 chapters:
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
A Comprehensive Resource for Gastroenterology and Hepatology
The 12th edition of "S. Gastroenterology and Liver Disease" is a highly regarded textbook that provides an in-depth review of the latest advances in gastroenterology and hepatology. As a leading resource in the field, this edition continues to deliver authoritative and comprehensive information on the diagnosis, treatment, and management of gastrointestinal and liver diseases.
Strengths:
Weaknesses:
Key Features:
Recommendation:
The 12th edition of "S. Gastroenterology and Liver Disease" is a valuable resource for:
Overall, this textbook remains a leading resource in gastroenterology and hepatology, providing a thorough and authoritative review of the field.
Rating: 5/5 stars